Jose Ignacio (Iñaki) Fortea's Avatar

Jose Ignacio (Iñaki) Fortea

@jifortea.bsky.social

12 Followers  |  4 Following  |  1 Posts  |  Joined: 13.12.2024  |  1.7438

Latest posts by jifortea.bsky.social on Bluesky

Post image Post image Post image Post image

🚨Just one month away‼️
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷

🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration -> app.evalandgo.com/f/325218/4qE...
📘 Full program below 👇 #LiverTwitter

05.11.2025 16:03 — 👍 2    🔁 2    💬 0    📌 0
Preview
Loss of Bile Salt Export Pump (Bsep/Abcb11) Ameliorates Toxin-induced Hepatic Fibrosis via Suppression of Hepatocellular Jun Amino-terminal Kinase Signaling and Hepatic Stellate Cell Activation Loss of Bsep/Abcb11 results in a hydrophilic bile acid (BA) pool consisting of tetrahydroxylated BAs (THBAs) reducing cholestasis-induced liver injury. In this study, we investigated whether loss of B...

Loss of Bile Salt Export Pump (Bsep/Abcb11) Ameliorates Toxin-induced Hepatic Fibrosis via Suppression of Hepatocellular Jun Amino-terminal Kinase Signaling and Hepatic Stellate Cell Activation -

Cellular and Molecular Gastroenterology and Hepatology
www.cmghjournal.org/article/S235...

27.10.2025 20:29 — 👍 4    🔁 2    💬 0    📌 0
Post image Post image

💶Fees (VAT included)

In-person:
🧑‍🔬 Early bird: €800 → After: €1000
👩‍⚕️ Nurses/HCA: €500
🎓 Young investigators (<40 yrs): €700
👶 Symposium only: €122

Virtual:
🌐 General: €800
🎓 €500
@BavenoCoop
members: €100 off (except 🎓)

Register at: baveno8.org/registration

27.10.2025 13:45 — 👍 1    🔁 1    💬 0    📌 0
Post image

Important Deadlines for #BavenoVIII ‼️

💶 Early registration: 15 Dec 2025
🪶 Abstract submission: 15 Jan 2026
📄 Satellite programmes & speakers: 15 Jan 2026
📦 Sponsor material delivery at venue: 20 Mar 2026
Stay tuned for updates -> 🔗 baveno8.org

#LiverTwitter

27.10.2025 13:45 — 👍 1    🔁 1    💬 1    📌 0
Post image

⏳ Just 5 months left for #BavenoVIII!
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵

27.10.2025 13:45 — 👍 2    🔁 2    💬 1    📌 0
Post image Post image Post image Post image

@bavenocoop.bsky.social visiting the Japanese Society of Portal Hypertension

👀 at our auditorium

🙏 incredible hospitality

👉 See our 🇯🇵 friends at Baveno VIII

12.09.2025 09:53 — 👍 5    🔁 2    💬 0    📌 0
Post image

🚨 Mark your calendars! Baveno VIII Meeting → 27–28 March 2026

Reminder from @crisripoll.bsky.social, Baveno Vice-Secretary at #DGVS

⏳ only 6 months left!

Register 👉 bavenocoop.net

19.09.2025 15:25 — 👍 3    🔁 1    💬 0    📌 0
Preview
Muere Jaume Bosch, hepatólogo y expresidente de la AEEH entre 2013 y 2015 Fue el primer director científico del Ciber de Enfermedades Hepáticas y Digestivas

Press
🗞️Redacción Médica: redaccionmedica.com/secciones/me...
🗞️Diario Médico: diariomedico.com/medicina/apa...
📰La Razón: larazon.es/cataluna/fal...
⚽️ Lagrada: lagradaonline.com/espanyol-due...

May his legacy continue to inspire, heal, and guide the future of hepatology. 🌿

04.09.2025 09:32 — 👍 2    🔁 1    💬 0    📌 0
Preview
In Memoriam: Professor Jaume Bosch (1947–2025) - CASL - Canadian Association for the Study of the Liver A giant in both humanity and science, Jaume was an extraordinary mentor and role model to countless physicians and researchers […]

🇨🇦 hepatology.ca/2025/07/17/i...
🇧🇷 sbhepatologia.org.br/noticias/not...
🇮🇹 AISF: dldjournalonline.com/action/showP...

Institutions
🏥Hospital Clínic / IDIBAPS: clinicbarcelona.org/en/news/deat...
🏛️CIBEREHD: ciberisciii.es/noticias/lam...

04.09.2025 09:32 — 👍 1    🔁 1    💬 1    📌 0
Post image

The passing of Prof. Jaume Bosch (1947–2025) has generated, and continues to generate, heartfelt tributes

Here you can read some of them:

Scientific societies
🇪🇺EASL: journal-of-hepatology.eu/action/showP...
🇪🇸AEEH: aeeh.es/obituario-ja...
🇨🇭SASL: sasl.unibas.ch/files/mixed%...

04.09.2025 09:32 — 👍 3    🔁 2    💬 2    📌 0
Preview
Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study Previous studies suggested that anticoagulation decreases the probability of developing portal hypertension (PHT)-related complications and improves survival in cirrhotic patients. Our study aimed to ...

CIRROXABAN Study is finally here!
🔬 First DB RCT evaluating rivaroxaban in cirrhosis
💡 Complication-free survival benefit in moderate liver dysfunction—Child‑Pugh B7 (HR 0.26 [95 % CI 0.07–0.90]).
⚠️ Mild bleeding ↑, but no increase in severe events.
📄 www.journal-of-hepatology.eu/article/S016...

22.07.2025 09:29 — 👍 3    🔁 1    💬 0    📌 0
Post image Post image

🇳🇱 Join us at #EASL2025 in Amsterdam 🇳🇱

📅 Thu 08 May
08:30–09:45 | Future of Hepatology: Endohepatology
10:00–10:30 | Baveno @ EASL Track Hub (Cirrhosis & Complications)

📅 Fri 09 May
12:00–13:30 | Baveno General Assembly (Room D201, members only)

#LiverTwitter

05.05.2025 05:19 — 👍 4    🔁 4    💬 0    📌 0
Post image Post image

🚨Missed it or want to dive deeper into the Baveno VIII Pre-Symposium Webinar: Designing Clinical Studies in Advanced Chronic Liver Disease?

📺It’s now available on demand at bavenocoop.net — members only.

🫂Membership is free

You’re so welcome 😉

29.03.2025 09:38 — 👍 3    🔁 2    💬 0    📌 0

🚨 Today is the day 🚨

The #Baveno8 Pre-Symposium Webinar is happening today 🎉

🔬 Cutting-edge topics on ACLD, Win Ratio, Bayesian inference, surrogate outcomes, and more‼️

⏳ Don't miss it ‼️

🔗 baveno8.org/presymposium/
💰 Free for members | €100 non-members

05.03.2025 08:13 — 👍 1    🔁 3    💬 0    📌 0
Post image Post image

🚨 2 days to go‼️

✅ RCT challenges in ACLD
✅ Win ratio & ordinal outcomes
✅ Heterogeneity of Tx. effects
✅ Surrogate outcomes & Bayesian inference
✅ Methodological pitfalls in observ. studies

🔗 baveno8.org/presymposium/
🗓️ March 5
💰 Free for members | €100 non-members

03.03.2025 08:09 — 👍 2    🔁 2    💬 0    📌 0
Post image Post image

And last but not least...

💡Uncover the methodological pitfalls in observational studies in Hepatology. Ensure your research is robust and reliable‼️

⌛ Just 1️⃣ week to go!

🔗Register: baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members 👇

25.02.2025 11:11 — 👍 1    🔁 2    💬 0    📌 0
Post image Post image

❓How can Bayesian inference enhance RCTs and observational studies?

💡Discover how to leverage this powerful approach to improve clinical research design

⏰ The clock is ticking‼️

🔗Register: baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members

21.02.2025 16:11 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image

❓How are surrogate outcomes validated as efficacy endpoints?

💡Learn the regulatory perspective on validation requirements and how to assess treatment response with insights from the EMA.

🔗Register: baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members 👇

12.02.2025 06:53 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image

❓Do all patients respond the same way to treatment in ACLD?

💡Identify responders vs. non-responders, assess effect sizes, and explore novel approaches beyond subgroup analysis.

🔗Register: baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members

01.02.2025 11:17 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image

❓How can we go beyond binary outcomes in assessing treatment effects in ACLD?

💡Learn about hierarchical outcomes, recurrent & competing events, ordinal analysis, and the Win Ratio

🔗Register: baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members

👇

21.01.2025 12:59 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image

🌟 NEW YEAR, NEW HORIZONS‼️

❓What are the current challenges in designing clinical trials in ACLD? How to measure success in cACLD, dACLD, and even recompensated cirrhosis?

🔗Registration at baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members 👇

09.01.2025 06:45 — 👍 2    🔁 1    💬 0    📌 0

🎄 Wishing everyone a Merry Christmas and Happy Holidays from all of us at @bavenocoop.bsky.social ‼️

✨ Here's to a joyful season and a 2025 filled with groundbreaking advancements for our patients—the heart of our profession 🧭🫂

👩‍🔬Thanks to all our colleagues for our shared mission‼️

22.12.2024 09:49 — 👍 2    🔁 1    💬 0    📌 0
Post image

🚨 It is finally here‼️

📜 Carvedilol vs. Propranolol for preventing decompensation and mortality in compensated & decompensated cirrhosis

📎 journal-of-hepatology.eu/article/S016...

🫂 Huge thanks to all coauthors! 🙌

18.12.2024 15:57 — 👍 3    🔁 2    💬 1    📌 0

🌟 Excited to announce that we've officially joined BlueSky!

🏠 Welcome to the official account of The Baveno Cooperation: an EASL Consortium. We're here to share insights, updates, and advancements in liver research!

🌐 Stay tuned for more! 🚀

13.12.2024 16:09 — 👍 3    🔁 2    💬 1    📌 1
Post image Post image

🚨Don’t miss the Baveno VIII Pre-Symposium Webinar: Designing Clinical Studies in Advanced Chronic Liver Disease

A must-attend for all liver lovers!

🗓️Wednesday, March 5, 2025
🔗Register and more info at baveno8.org/presymposium/

13.12.2024 16:13 — 👍 2    🔁 1    💬 0    📌 0

@jifortea is following 4 prominent accounts